Fanny Leenhardt

8PUBLICATIONS
17CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsClinical pharmacy and pharmacy practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2026
Antacid co-treatment and pregnane X receptor genetic polymorphisms are survival determinants in patients treated with palbociclib.

|Jul 27, 2024
Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report.

Charlotte Donzé, Fanny Leenhardt, Marie Vinches

|Mar 29, 2023
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key.

Quentin Dominique Thomas, Nelly Firmin, Litaty Mbatchi

|Feb 18, 2022
Oral targeted therapy dose adaptation in older patients with cancer: A real-life French cohort.

Clément Carbasse, Fanny Leenhardt, William Jacot

|Jul 24, 2021
PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1.

Alice Matheux, Matthieu Gassiot, Gaëlle Fromont

|Jul 21, 2021
Impact of pharmacist consultation at clinical trial inclusion: an effective way to reduce drug-drug interactions with oral targeted therapy.

Fanny Leenhardt, Marie Alexandre, Severine Guiu

Pageof 2

Frequent Collaborators

1 joint publications

Félicien Le Louedec

1 joint publications

Matthieu Gassiot

1 joint publications

Gaëlle Fromont

1 joint publications

Abdelhay Boulahtouf